Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06570265

RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane)

Evaluation of Resorption, Safety, and Efficacy of Absorbable Collagen Membrane in Preventing Significant Bone Loss Following GBR (Guided Bone Regeneration) Procedure.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Hyundai Bioland Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The clinical study aims to assess the long-term safety and efficacy of the interventional medical device. The clinical study will enrol up to 50 patients aged 18 years and older, who meet specific inclusion and exclusion criteria designed to ensure patient safety and reliable data collection.

Conditions

Interventions

TypeNameDescription
DEVICEGBR membraneGBR procedure is a technique often used in conjunction with dental implants to enhance the success and stability of the implant. This technique involves using barrier membranes to protect the bone graft or defect site from the rapid proliferation of surrounding soft tissues. In this clinical investigation resorbable, collagen membrane will be used.

Timeline

Start date
2024-12-16
Primary completion
2026-05-16
Completion
2026-06-30
First posted
2024-08-26
Last updated
2024-08-26

Source: ClinicalTrials.gov record NCT06570265. Inclusion in this directory is not an endorsement.

RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane) (NCT06570265) · Clinical Trials Directory